glp-1 cv outcome trials Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes Clinical Outcomes with GLP-1 Receptor
Description
Trulicity Trulicity is another GLP-1 receptor agonist drug manufactured by Eli Lilly and Company
Simple, transparent careno subscriptions, no hidden fees
The available data doesnt show major differences between the two drugs for menstrual effects
Psychological & Physiological Dependence Patients may develop a psychological or physiological reliance on GLP-1 medications, complicating the discontinuation process
9-11 This review should be concluded with the acknowledgement of an important limitationthese trials had a relatively short duration
